{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:41:24Z","timestamp":1789648884052,"version":"4.0.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-240","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T06:17:51Z","timestamp":1369376271000},"source":"Crossref","is-referenced-by-count":41,"title":["Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays"],"prefix":"10.1186","volume":"13","author":[{"given":"Danila V","family":"Zimenkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V","family":"Kuz\u2019min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia D","family":"Isaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila Y","family":"Krylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S","family":"Zasedatelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir M","family":"Mikhailovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A","family":"Gryadunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"issue":"5","key":"2449_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1128\/AAC.01550-10","volume":"55","author":"PJ Campbell","year":"2011","unstructured":"Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE: Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011, 55 (5): 2032-2041. 10.1128\/AAC.01550-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2449_CR2","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1128\/AAC.00707-11","volume":"55","author":"A Pantel","year":"2011","unstructured":"Pantel A, Petrella S, Matrat S, Brossier F, Bastian S, Reitter D, Jarlier V, Mayer C, Aubry A: DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011, 55 (10): 4524-4529. 10.1128\/AAC.00707-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2449_CR3","doi-asserted-by":"publisher","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","volume":"7","author":"S Malik","year":"2012","unstructured":"Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE: New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations. PLoS One. 2012, 7 (6): e39754-10.1371\/journal.pone.0039754.","journal-title":"PLoS One"},{"issue":"1","key":"2449_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","volume":"50","author":"A Aubry","year":"2006","unstructured":"Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher LM: Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother. 2006, 50 (1): 104-112. 10.1128\/AAC.50.1.104-112.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2449_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10096-007-0298-0","volume":"26","author":"N Veziris","year":"2007","unstructured":"Veziris N, Martin C, Brossier F, Bonnaud F, Denis F, Aubry A: Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance. Eur J Clin Microbiol Infect Dis. 2007, 26 (6): 423-425. 10.1007\/s10096-007-0298-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"2449_CR6","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1128\/AAC.00042-11","volume":"55","author":"H Kim","year":"2011","unstructured":"Kim H, Nakajima C, Yokoyama K, Rahim Z, Kim YU, Oguri H, Suzuki Y: Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance. Antimicrob Agents Chemother. 2011, 55 (8): 3661-3667. 10.1128\/AAC.00042-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2449_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1128\/AAC.06272-11","volume":"56","author":"A Pantel","year":"2012","unstructured":"Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A: Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis. Antimicrob Agents Chemother. 2012, 56 (4): 1990-1996. 10.1128\/AAC.06272-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2449_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/jac\/dkr566","volume":"67","author":"F Maruri","year":"2012","unstructured":"Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A: A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother. 2012, 67 (4): 819-831. 10.1093\/jac\/dkr566.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2449_CR9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.36.5.1220-1225.1998","volume":"36","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y, Katsukawa C, Tamaru A, Abe C, Makino M, Mizuguchi Y, Taniguchi H: Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol. 1998, 36 (5): 1220-1225.","journal-title":"J Clin Microbiol"},{"issue":"47","key":"2449_CR10","doi-asserted-by":"publisher","first-page":"20004","DOI":"10.1073\/pnas.0907925106","volume":"106","author":"MA Zaunbrecher","year":"2009","unstructured":"Zaunbrecher MA, Sikes RD, Metchock B, Shinnick TM, Posey JE: Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2009, 106 (47): 20004-20009.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2449_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM: Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005, 49 (2): 571-577. 10.1128\/AAC.49.2.571-577.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2449_CR12","doi-asserted-by":"publisher","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","volume":"7","author":"SB Georghiou","year":"2012","unstructured":"Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC: Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review. PLoS One. 2012, 7 (3): e33275-10.1371\/journal.pone.0033275.","journal-title":"PLoS One"},{"issue":"6","key":"2449_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/JCM.00081-09","volume":"47","author":"D Hillemann","year":"2009","unstructured":"Hillemann D, Rusch-Gerdes S, Richter E: Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009, 47 (6): 1767-1772. 10.1128\/JCM.00081-09.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2449_CR14","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/AAC.00050-09","volume":"53","author":"S Feuerriegel","year":"2009","unstructured":"Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rusch-Gerdes S, Niemann S: Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother. 2009, 53 (8): 3353-3356. 10.1128\/AAC.00050-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2449_CR15","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/JCM.06664-11","volume":"50","author":"A Engstrom","year":"2012","unstructured":"Engstrom A, Morcillo N, Imperiale B, Hoffner SE, Jureen P: Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing. J Clin Microbiol. 2012, 50 (6): 2026-2033. 10.1128\/JCM.06664-11.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2449_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1586\/erm.11.73","volume":"11","author":"D Gryadunov","year":"2011","unstructured":"Gryadunov D, Dementieva E, Mikhailovich V, Nasedkina T, Rubina A, Savvateeva E, Fesenko E, Chudinov A, Zimenkov D, Kolchinsky A: Gel-based microarrays in clinical diagnostics in Russia. Expert Rev Mol Diagn. 2011, 11 (8): 839-853. 10.1586\/erm.11.73.","journal-title":"Expert Rev Mol Diagn"},{"key":"2449_CR17","first-page":"1","volume-title":"WHO\/TB\/98258","author":"WHO","year":"1998","unstructured":"WHO: Laboratory Services in Tuberculosis Control. Part II: Microscopy. WHO\/TB\/98258. 1998, Geneva: WHO, 1-62."},{"issue":"4","key":"2449_CR18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JCM.35.4.907-914.1997","volume":"35","author":"J Kamerbeek","year":"1997","unstructured":"Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35 (4): 907-914.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2449_CR19","first-page":"1449","volume":"12","author":"C Rodrigues","year":"2008","unstructured":"Rodrigues C, Jani J, Shenai S, Thakkar P, Siddiqi S, Mehta A: Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis. 2008, 12 (12): 1449-1455.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2449_CR20","first-page":"1","volume-title":"WHO\/HTM\/TB\/2008392","author":"WHO","year":"2008","unstructured":"WHO: Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. WHO\/HTM\/TB\/2008392. 2008, Geneva: WHO, 1-20."},{"issue":"1","key":"2449_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ab.2003.10.010","volume":"325","author":"AY Rubina","year":"2004","unstructured":"Rubina AY, Pan'kov SV, Dementieva EI, Pen'kov DN, Butygin AV, Vasiliskov VA, Chudinov AV, Mikheikin AL, Mikhailovich VM, Mirzabekov AD: Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Anal Biochem. 2004, 325 (1): 92-106. 10.1016\/j.ab.2003.10.010.","journal-title":"Anal Biochem"},{"issue":"7","key":"2449_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1469-0691.2005.01183.x","volume":"11","author":"D Gryadunov","year":"2005","unstructured":"Gryadunov D, Mikhailovich V, Lapa S, Roudinskii N, Donnikov M, Pan'kov S, Markova O, Kuz'min A, Chernousova L, Skotnikova O: Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect. 2005, 11 (7): 531-539. 10.1111\/j.1469-0691.2005.01183.x.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2449_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/jac\/dkm054","volume":"59","author":"RC Chan","year":"2007","unstructured":"Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC: Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother. 2007, 59 (5): 866-873. 10.1093\/jac\/dkm054.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2449_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1086\/315708","volume":"182","author":"J Zhou","year":"2000","unstructured":"Zhou J, Dong Y, Zhao X, Lee S, Amin A, Ramaswamy S, Domagala J, Musser JM, Drlica K: Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis. 2000, 182 (2): 517-525. 10.1086\/315708.","journal-title":"J Infect Dis"},{"issue":"2","key":"2449_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jinf.2010.05.001","volume":"61","author":"X Yin","year":"2010","unstructured":"Yin X, Yu Z: Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect. 2010, 61 (2): 150-154. 10.1016\/j.jinf.2010.05.001.","journal-title":"J Infect"},{"issue":"5","key":"2449_CR26","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/JCM.01947-09","volume":"48","author":"F Brossier","year":"2010","unstructured":"Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W: Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2010, 48 (5): 1683-1689. 10.1128\/JCM.01947-09.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"2449_CR27","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/AAC.00287-09","volume":"53","author":"A Von Groll","year":"2009","unstructured":"Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA: Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother. 2009, 53 (10): 4498-4500. 10.1128\/AAC.00287-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2449_CR28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jac\/dkr109","volume":"66","author":"A Engstrom","year":"2011","unstructured":"Engstrom A, Perskvist N, Werngren J, Hoffner SE, Jureen P: Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2011, 66 (6): 1247-1254. 10.1093\/jac\/dkr109.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2449_CR29","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/JCM.00197-11","volume":"49","author":"WL Huang","year":"2011","unstructured":"Huang WL, Chi TL, Wu MH, Jou R: Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011, 49 (7): 2502-2508. 10.1128\/JCM.00197-11.","journal-title":"J Clin Microbiol"},{"key":"2449_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6890-9-2","volume":"9","author":"V Nikolayevskyy","year":"2009","unstructured":"Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F: Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol. 2009, 9: 2-10.1186\/1472-6890-9-2.","journal-title":"BMC Clin Pathol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-240\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T23:43:36Z","timestamp":1595807016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2449"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-240","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]},"article-number":"240"}}